
Johnson & Johnson
OrganizationOn 6 shows in Markets & Investing this week · 0.9× usual · most on Brew Markets
Johnson & Johnson is an American multinational healthcare company focused on pharmaceutical medicines and medical technologies, including medical devices. The podcast references primarily concern the publicly traded parent company, its pharmaceutical and medical-device businesses, earnings and stock performance, and its former consumer-health portfolio, which was separated into Kenvue in 2023 rather than remaining part of J&J.
Rank this week
Share of the conversation
0.1‰ of what listeners heard
Reach this week
Tone this week
- Neutral 4
- Positive 1
Share of the conversation
Mentions of Johnson & Johnson per 1,000 mentions of anything, 7-day rolling, markets & investing.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Oct 8 | 0.21‰ | 1 |
| Oct 9 | 0.40‰ | 3 |
| Oct 10 | 0.46‰ | 1 |
| Oct 12 | 0.39‰ | 1 |
| Oct 13 | 0.98‰ | 9 |
| Oct 14 | 1.07‰ | 2 |
| Oct 15 | 1.10‰ | 2 |
| Oct 16 | 1.06‰ | 2 |
| Oct 19 | 1.05‰ | 2 |
| Oct 20 | 0.62‰ | 2 |
| Oct 21 | 0.76‰ | 4 |
| Oct 22 | 0.77‰ | 2 |
| Oct 26 | 0.68‰ | 3 |
| Oct 27 | 0.73‰ | 3 |
| Oct 29 | 0.42‰ | 1 |
| Oct 30 | 0.54‰ | 2 |
| Oct 31 | 0.59‰ | 1 |
| Nov 2 | 0.47‰ | 1 |
| Nov 3 | 0.41‰ | 2 |
| Nov 4 | 0.45‰ | 1 |
| Nov 5 | 0.45‰ | 1 |
| Nov 6 | 0.45‰ | 2 |
| Nov 9 | 0.39‰ | 1 |
| Nov 12 | 0.40‰ | 4 |
| Nov 14 | 0.38‰ | 2 |
| Nov 16 | 0.42‰ | 2 |
| Nov 17 | 0.51‰ | 2 |
| Nov 18 | 0.57‰ | 1 |
| Nov 19 | 0.40‰ | 1 |
| Nov 20 | 0.51‰ | 2 |
Why is it trending?· Last 7 days
Not explained yet. Pro writes it up from the podcast moments, with every sentence linked to its source.
Who is saying what about Johnson & Johnson
Verified quotes from the last 90 days: who made the most claims, and which way they leaned.
- Jim Cramer11 claims on 1 show
“Own the stock.”
Mad Money w/ Jim Cramer · Nov 3 ↗ - Guy Adami2 claims on 1 show
“J&J is going higher.”
CNBC's "Fast Money" · Nov 12 ↗ - Lauren Martz1 claim on 1 show
“There's another 1.1 or a little more. in regulatory and commercial milestones.”
BioCentury This Week · Nov 17 ↗
5 more with Pro.
Discussed alongside
Names that come up in the same conversations as Johnson & Johnson.
Embed this
Paste this on your site to show Johnson & Johnson's current trend:
<iframe src="https://podlume.ai/embed/e/johnson-johnson" width="360" height="220" style="border:0" loading="lazy" title="Johnson & Johnson on PodLume Trends"></iframe>